Domo and Regional One Health Named 2023 Nucleus ROI Award Winners
Retrieved on:
Monday, September 18, 2023
Domo (Nasdaq: DOMO) announced today that it and Regional One Health , a national leader in healthcare, received a Nucleus Research ROI Award for achieving a total ROI of 190% through the adoption of Domo’s data experience platform.
Key Points:
- Domo (Nasdaq: DOMO) announced today that it and Regional One Health , a national leader in healthcare, received a Nucleus Research ROI Award for achieving a total ROI of 190% through the adoption of Domo’s data experience platform.
- The platform enabled significant improvements in patient care, advanced operational efficiencies and revenue for Regional One Health.
- As a premier healthcare organization, Regional One Health aims to transform the way it delivers healthcare through informed, data-driven decisions.
- “We talk a lot about multiplying impact through data and Regional One Health embodies absolutely that in their day to day work,” said Mark Maughan, SVP of customer success at Domo.